No active 13F manager changed its position in BIOF last quarter. Over the last 180 days, 1 insider sold and none bought, a net -$141K in open-market trades.
The legs disagree, or only one of them leans.
2 tracked 13F filers disclose a position in BIOF as of the latest SEC 13F filings, a combined $37K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Ancora Advisors LLC | 280K | $34K | —Held | Q2 2026 | |
| 2 | Atlas Wealth LLC | 24K | $3K | —Held | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Company | Co-held by | Their position there |
|---|---|---|
| LKQ CorpLKQ | 1 funds | $236.3M |
| Apple IncAAPL | 1 funds | $135.3M |
| Americold Realty Trust IncCOLD | 1 funds | $133.1M |
| Broadcom IncAVGO | 1 funds | $128.1M |
| Vanguard S&P 500 ETFVOO | 1 funds | $120.6M |
| RB Global IncRBA | 1 funds | $117.7M |
| Ishares Core S&P Total U.S.ITOT | 1 funds | $100.4M |
| JPMorgan Ultra-Short IncomeJPST | 1 funds | $90.6M |
| Microsoft CorpMSFT | 1 funds | $88.6M |
| JPMorgan Chase & CoJPM | 1 funds | $82.5M |
| Abbvie IncABBV | 1 funds | $69.1M |
| Eaton Corp PLCETN | 1 funds | $65.3M |
Ranked by how many of BIOF's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in BIOF.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Kneppers Chris J | Director | Sell (S) | 300K | $30K |
| Sep 4, 2026 | Kneppers Chris J | Director | Sell (S) | 200K | $20K |
| Sep 3, 2026 | Kneppers Chris J | Director | Sell (S) | 100K | $10K |
| Sep 2, 2026 | Kneppers Chris J | Director | Sell (S) | 700K | $63K |
| Sep 1, 2026 | Kneppers Chris J | Director | Sell (S) | 200K | $18K |
| May 2, 2022 | Santelli Anthony II | CFO, Director | Buy (P) | 500K | $75K |
| Apr 27, 2022 | Slager Benjamin | CEO, Director, 10% Owner | Buy (P) | 500K | $75K |
| Feb 5, 2021 | Santelli Anthony II | CFO, Director, 10% Owner | Sell (S) 3 lots, same day | 1.5M | $1.2M |
| Feb 4, 2021 | Santelli Anthony II | CFO, Director, 10% Owner | Sell (S) 3 lots, same day | 536K | $346K |
| Feb 3, 2021 | Santelli Anthony II | CFO, Director, 10% Owner | Sell (S) 2 lots, same day | 167K | $104K |
| Feb 2, 2021 | Santelli Anthony II | CFO, Director, 10% Owner | Sell (S) 2 lots, same day | 69K | $41K |
| Jan 28, 2021 | Santelli Anthony II | CFO, Director, 10% Owner | Sell (S) 2 lots, same day | 120K | $82K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 0 | 0 | – |
Insiders Form 4 open-market | 0 | 1 | -$141K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for BIOF
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/BIOF/capital-change-brief"
Use Arkolith's capital_change_brief for BIOF. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for BIOF. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.